Medicines containing the active substances Vilanterol and Umeclidinium bromide (ATC: R03AL03)
AOK Sachsen - Anhalt, MagdeburgTED 513665-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Medical supplies contracts
4,401 open tenders
Email me new onesCountryTenderValueClosesDays left
Medicines containing the active substance Tocilizumab (ATC: L04AC07)
AOK Sachsen - Anhalt, MagdeburgTED 542317-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Medicines with the Active Substance Rasagiline (ATC: N04BD02)
AOK Sachsen - Anhalt, MagdeburgTED 512414-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Medicines containing the active substance Naproxen (ATC: M01AE02)
AOK Sachsen - Anhalt, MagdeburgTED 515276-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Medicines containing the active substance Golimumab (ATC: L04AB06)
AOK Sachsen - Anhalt, MagdeburgTED 542028-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Medicines containing the active substance Testosterone (ATC: G03BA03) in the form of Gel
AOK Sachsen - Anhalt, MagdeburgTED 589436-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Medicines with the active substance Aprepitant (ATC: A04AD12) in the form of hard capsules
AOK Sachsen - Anhalt, MagdeburgTED 515102-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Medicines containing the active substance Entecavir (ATC: J05AF10) in the form of film-coated tablets
AOK Sachsen - Anhalt, MagdeburgTED 512862-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Medicines containing the active substance Irbesartan and Hydrochlorothiazide (ATC: C09DA24)
AOK Sachsen - Anhalt, MagdeburgTED 515048-2026
value not stated1 lot, 2 years
Mon 31 Jul
641days
Open House Procedure for Collective Means
AOK Rheinland/Hamburg - Die Gesundheitskasse, DüsseldorfTED 372695-2026
value not stated1 lot, 2 years
Mon 31 Jul12:00 in Berlin
641days
Open House Originals Rebate Contracts 2026 - 05 Alectinib
Techniker Krankenkasse, HamburgTED 455118-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
641days
Open House Biologics Rebate Contracts 2026 - 26 - Tralokinumab
Techniker Krankenkasse, HamburgTED 418152-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
641days
Open House Biologics Rebate Agreements 2026 – 20 – Peginterferon beta 1a
Techniker Krankenkasse, HamburgTED 372206-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
641days
Open House Rebate Contracts 2026-10
Techniker Krankenkasse, HamburgTED 413055-2026
value not stated11 lots
Mon 31 Jul23:58 in Berlin
641days
Open House Biologics Rebate Contracts 2026-25 - Follitropin alfa
Techniker Krankenkasse, HamburgTED 388432-2026
value not stated3 lots
Mon 31 Jul23:58 in Berlin
641days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Lanthanum(III) carbonate in the dosage form chewable tablets
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 344198-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
641days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Peginterferon beta-1a (WHO ATC Code: L03AB13)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 343454-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
641days
Open House Biologics Rebate Contracts 2026-23 - Darbepoetin alfa
Techniker Krankenkasse, HamburgTED 387146-2026
value not stated3 lots
Mon 31 Jul23:58 in Berlin
641days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Somatropin (WHO ATC Code: H01AC01)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 345458-2026
value not stated1 lot
Mon 31 Jul23:58 in Berlin
641days
Open House Rebate Contracts 2024 - 08
Techniker Krankenkasse, HamburgTED 453219-2026
value not stated25 lots
Mon 31 Jul23:58 in Berlin
641days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.